Brinzolamide

‌Brinzolamide | USP/EP-Certified Bulk API for Glaucoma Therapy & Ophthalmic Formulations‌

🔬 ‌Product Overview‌

Brinzolamide, a ‌topical carbonic anhydrase inhibitor (CAI)‌, is widely used in ‌glaucoma treatment‌ and ‌ocular hypertension management‌ to reduce intraocular pressure (IOP) by suppressing aqueous humor production‌14. Its high selectivity and minimal systemic absorption make it ideal for sustained ophthalmic drug delivery‌13.

🌟 ‌Key Features‌

• ‌Regulatory Compliance‌

  : Manufactured under 

  ‌USP/EP standards‌

   with ≥99% HPLC purity for pharmaceutical-grade applications‌35.

• ‌Enhanced Stability‌

  : 24-month shelf life in sealed, light-protected packaging (2-8°C storage)‌56.

• ‌Mechanistic Precision‌

  : Targets CA-II isoenzymes in ciliary processes, ensuring localized efficacy without compromising corneal clarity‌14.

💊 ‌Applications‌

• ‌Ophthalmic Solutions‌

  : Core API in 

  ‌glaucoma eye drops‌

   (e.g., Azopt® generics) and 

  ‌combination therapies‌

   with beta-blockers‌34.

• ‌Research Use‌

  : Critical for 

  ‌ocular pharmacology studies‌

   and 

  ‌novel CA inhibitor development‌

  ‌16.

📜 ‌Quality Assurance‌

• ‌Batch Documentation‌

  : COA, MSDS, and ICH-compliant impurity profiles (total impurities <0.2%)‌56.

• ‌Packaging Options‌

  : Available in 

  ‌100g amber glass bottles‌

   and 

  ‌5kg vacuum-sealed HDPE containers‌

  ‌36.